Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) was up 6.2% during trading on Wednesday . The stock traded as high as $81.85 and last traded at $80.80. Approximately 720,124 shares changed hands during mid-day trading, a decline of 29% from the average daily volume of 1,013,515 shares. The stock had previously closed at $76.10.
Wall Street Analysts Forecast Growth
HSIC has been the subject of several research analyst reports. Jefferies Financial Group increased their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Barrington Research reissued an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Evercore ISI lifted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $79.30.
Read Our Latest Research Report on HSIC
Henry Schein Trading Up 5.1 %
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the firm earned $1.32 earnings per share. On average, sell-side analysts expect that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.14% of the stock is owned by insiders.
Hedge Funds Weigh In On Henry Schein
Several institutional investors have recently bought and sold shares of the business. Clarkston Capital Partners LLC raised its stake in shares of Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after acquiring an additional 71,560 shares during the period. Nuance Investments LLC increased its stake in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares during the period. SG Americas Securities LLC lifted its position in shares of Henry Schein by 1,622.3% during the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after purchasing an additional 432,187 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Henry Schein during the 3rd quarter valued at about $515,000. Finally, Thrivent Financial for Lutherans boosted its position in Henry Schein by 1,848.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock valued at $7,685,000 after buying an additional 100,006 shares during the period. Institutional investors own 96.62% of the company’s stock.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
- Five stocks we like better than Henry Schein
- What Are Earnings Reports?
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- There Are Different Types of Stock To Invest In
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.